Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome in Older Adults.
- Author(s): Scott, Jake
- Goetz, Matthew Bidwell
- et al.
Published Web Locationhttps://doi.org/10.1016/j.cger.2016.02.010
Improved survival with combination antiretroviral therapy has led to a dramatic increase in the number of human immunodeficiency virus (HIV)-infected individuals 50 years of age or older such that by 2020 more than 50% of HIV-infected persons in the United States will be above this age. Recent studies confirm that antiretroviral therapy should be offered to all HIV-infected patients regardless of age, symptoms, CD4+ cell count, or HIV viral load. However, when compared with HIV-uninfected populations, even with suppression of measurable HIV replication, older individuals are at greater risk for cardiovascular disease, malignancies, liver disease, and other comorbidities.